All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| N-docosanoyl-15-methylhexadecasphinganine | CHEBI_74178 | [A N-acyl-15-methylhexadecasphinganine in which the acyl group has 22 carbons and 0 double bonds.] |
| N-tricosanoyl-15-methylhexadecasphinganine | CHEBI_74179 | [A N-acyl-15-methylhexadecasphinganine in which the acyl group has 23 carbons and 0 double bonds.] |
| 2-amino-1,3,4-tetradecanetriol | CHEBI_131750 | [A tetrol that is 2-aminotetradecane with the theree hydroxy substituents located at position 1, 3, and 4.] |
| N-tetradecanoyl-15-methylhexadecasphinganine | CHEBI_74170 | [A N-acyl-15-methylhexadecasphinganine in which the acyl group has 14 carbons and 0 double bonds.] |
| N-pentadecanoyl-15-methylhexadecasphinganine | CHEBI_74171 | [A N-acyl-15-methylhexadecasphinganine in which the acyl group has 15 carbons and 0 double bonds.] |
| N-hexadecanoyl-15-methylhexadecasphinganine | CHEBI_74172 | [A N-acyl-15-methylhexadecasphinganine in which the acyl group has 16 carbons and 0 double bonds.] |
| CMP-5'-phosphonoformic acid | CHEBI_131759 | [A cytidine 5'-phosphate obtained by formal condensation of the phosphate group of CMP with the phosphono group of phosphonoformic acid.] |
| CMP-5'-phosphonoformate(3-) | CHEBI_91255 | [An organophosphate oxoanion obtained by removal of three protons from CMP-5'-phosphonoformic acid; major species at pH 7.3.] |
| phosphonoformic acid | CHEBI_127780 | [Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.] |
| apigenin C-pentoside | CHEBI_131755 | [A flavone C-glycoside that is apigenin carrying one or more pentosyl substituents.] |
| tioxazafen | CHEBI_131756 | [A 1,2,4-oxadizole in which the hydrogens at positions 3 and 5 have been replaced by phenyl and thiophen-2-yl groups, respectively. It is used as a broad spectrum nematicidal seed treatment.] |
| C-pentosyl-apigenin O-feruloylhexoside | CHEBI_131757 | |
| 6-C-(alpha-L-arabinosyl)-8-C-(beta-L-arabinosyl)chrysoeriol | CHEBI_131758 | [A flavone C-glycoside that consists of chrysoeriol carrying alpha-L-arabinosyl and beta-L-arabinosyl groups at positions 6 and 8 respectively] |
| N-pentadecanoyl-15-methylhexadecasphing-4-enine | CHEBI_74184 | [A N-acyl-15-methylhexadecasphing-4-enine in which the acyl group has 15 carbons and 0 double bonds.] |
| N-acyl-15-methylhexadecasphing-4-enine | CHEBI_70846 | [Any ceramide having 15-methylhexadecasphing-4-enine as the sphingoid component.] |
| 15-methylhexadecasphing-4-enine | CHEBI_70798 | [A sphingoid that is hexadecasphing-4-enine substituted at position 15 by a methyl group.] |
| dodecyldimethylamine N-oxide | CHEBI_131762 | [A tertiary amine oxide resulting from the formal oxidation of the amino group of dodecyldimethylamine.] |
| dodecane | CHEBI_28817 | [A straight-chain alkane with 12 carbon atoms. It has been isolated from the essential oils of various plants including Zingiber officinale (ginger).] |
| N-tetracosenoyl-C17-sphingosine | CHEBI_74185 | [A ceramide in which the N-acyl moiety contains 24 carbons and 1 double bond, with the sphingoid base specified as C17-sphingosine.] |
| (1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl){4-[(6-methoxypyridazin-3-yl)sulfamoyl]anilino}methanesulfonic acid | CHEBI_131763 | [A sulfonamide that is aminomethanesulfonic acid in which a hydrogen attached to the carbon has been replaced by a 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl group and in which a hydrogen attached to the amino group has been replaced by a p-[(6-methoxypyridazin-3-yl)sulfamoyl]phenyl group.] |